Home
About
Overview
Sharing Data
ORCID
Help
History (27)
Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program.
Blood pressure reduction and outcome after endovascular therapy: a secondary analysis of the BEST study.
Aminosalicylates: old and new.
Drug Trials in Inflammatory Bowel Diseases 1993-1995: A Survey Conducted by the IOIBD.
Immunosuppressive therapy in the formation of antibodies to infliximab in Crohn's disease.
See All 27 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immunosuppressive therapy in the formation of antibodies to infliximab in Crohn's disease.
Immunosuppressive therapy in the formation of antibodies to infliximab in Crohn's disease. Curr Gastroenterol Rep. 2007 Dec; 9(6):487-8.
View in:
PubMed
authors with profiles
Stephen B. Hanauer